CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CICON16: The Future of Cancer Immunotherapy

    CICON16 ended by focusing on emerging treatments and technologies in cancer immunotherapy.

    October 5, 2016| Arthur N. Brodsky, PhD
  • CICON '16

    CICON16: The Power of Combinations

    Targeting tumors from multiple angles improves our odds of success.

    September 30, 2016| Arthur N. Brodsky, PhD
  • CICON16: Bacteria and Cancer Immunity

    New research shows that bacteria within us can influence both the development of cancer and the immune…

    September 28, 2016| Arthur N. Brodsky, PhD
  • CICON16: Corrupted by Cancer

    Day 2 of CICON16 explored strategies to overcome challenges within the tumor microenvironment.

    September 27, 2016| Arthur N. Brodsky, PhD
  • CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints

    The latest advances in using new checkpoint drugs to target LAG-3, Nrp1, IL-35R, CD36, and mitochondrial metabolism.

    September 26, 2016| Arthur N. Brodsky, PhD
  • CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches

    Antigens are the key to effective vaccines and the immune system’s ability to target cancer cells.

    September 26, 2016| Arthur N. Brodsky, PhD
  • CICON16: Translating Science Into Survival

    This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New…

    September 24, 2016| Arthur N. Brodsky, PhD
  • CICON15 Report from Day 4

    Highlights from the final day of the inaugural International Cancer Immunotherapy Conference.

    September 19, 2015| Matthew Tontonoz
  • CICON15 Report from Day 3

    Highlights from Day 3 of the inaugural International Cancer Immunotherapy Conference.

    September 18, 2015| Matthew Tontonoz
Previous Page
1 2 3 4
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute